A team of researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid. This promising inhibitor, named TMP1, offers hope for more effective […]
Rochester General Hospital, the University of Texas Southwestern Medical Center, and Aga Khan University report that applying newer cardiovascular risk equations could sharply reduce the number of middle-aged adults considered candidates for aspirin to prevent […]
The excessive and uncontrolled consumption of alcohol, which can culminate in the development of alcohol use disorder or alcoholism, is widespread in many countries worldwide. Individuals diagnosed with alcohol use disorder are often also experiencing […]
US regulators have approved an additional generic version of the abortion pill mifepristone, a normally routine move that nevertheless angered anti-abortion activists.This article was originally published on MedicalXpress.com
Early medical abortion at home up to 12 weeks of pregnancy is safe, effective, and comparable to hospital care, finds a five-year review of cases in Scotland, where this timeframe is legally permitted. The review […]
Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment. Addressing this unmet clinical need, researchers […]
Australia’s health system is one of the highest quality and most equitable in the world.This article was originally published on MedicalXpress.com
A new Northwestern Medicine study has shed light on how a class of diabetes drugs may protect the kidneys—not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to […]
Some people with autism spectrum disorder (ASD) have abnormal levels of glutamate in the brain. New research led by Mass General Brigham has focused on this neuron-activating chemical, suggesting that a glutamate-modulating drug called memantine […]
The U.S. Food and Drug Administration has approved Eli Lilly’s Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated advanced or metastatic […]
© 2025 SimplyWell.ca